In the context of therapies that seek to chronically increase leptin sensitivity for the treatment of obesity, these potentially negative aspects need to be considered and carefully evaluated in pre-clinical and clinical studies. Here, LEP is linked to obesity due to melanocortin 4 receptor deficiency.